These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 17959574

  • 1. Botulinum toxin type A for treatment of refractory gastroparesis.
    DeSantis ER, Huang S.
    Am J Health Syst Pharm; 2007 Nov 01; 64(21):2237-40. PubMed ID: 17959574
    [Abstract] [Full Text] [Related]

  • 2. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus.
    Lacy BE, Crowell MD, Schettler-Duncan A, Mathis C, Pasricha PJ.
    Diabetes Care; 2004 Oct 01; 27(10):2341-7. PubMed ID: 15451898
    [Abstract] [Full Text] [Related]

  • 3. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis.
    Ezzeddine D, Jit R, Katz N, Gopalswamy N, Bhutani MS.
    Gastrointest Endosc; 2002 Jun 01; 55(7):920-3. PubMed ID: 12024156
    [Abstract] [Full Text] [Related]

  • 4. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis.
    Bromer MQ, Friedenberg F, Miller LS, Fisher RS, Swartz K, Parkman HP.
    Gastrointest Endosc; 2005 Jun 01; 61(7):833-9. PubMed ID: 15933684
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle.
    Miller LS, Szych GA, Kantor SB, Bromer MQ, Knight LC, Maurer AH, Fisher RS, Parkman HP.
    Am J Gastroenterol; 2002 Jul 01; 97(7):1653-60. PubMed ID: 12135014
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Factors associated with symptom response to pyloric injection of botulinum toxin in a large series of gastroparesis patients.
    Coleski R, Anderson MA, Hasler WL.
    Dig Dis Sci; 2009 Dec 01; 54(12):2634-42. PubMed ID: 19184429
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Botulinum toxin for the treatment of gastroparesis: a preliminary report.
    Lacy BE, Zayat EN, Crowell MD, Schuster MM.
    Am J Gastroenterol; 2002 Jun 01; 97(6):1548-52. PubMed ID: 12094882
    [Abstract] [Full Text] [Related]

  • 14. Gastric per-oral endoscopic myotomy versus pyloric injection of botulinum toxin for the treatment of gastroparesis: our institutional experience and a systematic review of the literature.
    Tran D, Leeds SG, Fair L, Fang J, Rubarth C, McGowan T, Ramakrishnan S, Ogola G, Aladegbami B, Ward MA.
    Surg Endosc; 2023 Sep 01; 37(9):7280-7287. PubMed ID: 37430121
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients.
    Gil RA, Hwynn N, Fabian T, Joseph S, Fernandez HH.
    Parkinsonism Relat Disord; 2011 May 01; 17(4):285-7. PubMed ID: 21296606
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.